RCMNY
Rubric Capital Management (New York)’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $436M | Buy |
26,000,000
+450,000
| +2% | +$7.54M | 6.58% | 2 |
|
|
2025
Q1 | $393M | Buy |
25,550,000
+8,550,000
| +50% | +$131M | 7.04% | 2 |
|
|
2024
Q4 | $375M | Buy |
17,000,000
+994,502
| +6% | +$21.9M | 4.81% | 2 |
|
|
2024
Q3 | $288M | Sell |
16,005,498
-1,256,243
| -7% | -$22.6M | 4.7% | 2 |
|
|
2024
Q2 | $281M | Sell |
17,261,741
-407,847
| -2% | -$6.63M | 7.35% | 1 |
|
|
2024
Q1 | $249M | Sell |
17,669,588
-557,013
| -3% | -$7.86M | 7.37% | 1 |
|
|
2023
Q4 | $190M | Sell |
18,226,601
-773,399
| -4% | -$8.07M | 3.95% | 2 |
|
|
2023
Q3 | $194M | Buy |
19,000,000
+281,638
| +2% | +$2.87M | 7.27% | 1 |
|
|
2023
Q2 | $141M | Buy |
18,718,362
+14,218,556
| +316% | +$107M | 6.03% | 1 |
|
|
2023
Q1 | $39.8M | Buy |
+4,499,806
| New | +$39.8M | 1.03% | 23 |
|
|
2019
Q1 | – | Sell |
-830,000
| Closed | -$12.8M | – | 71 |
|
|
2018
Q4 | $12.8M | Buy |
+830,000
| New | +$12.8M | 1.58% | 24 |
|